CERC-002, a human anti-LIGHT mAb reduces respiratory failure and death in hospitalized COVID-19 ARDS patients

enthalten in: bioRxiv.org | 2021

von Perlin, D. | Neil, G. | Anderson, C. | +5

Rationale and prognosis of repurposed drugs with risk stratification of COVID-19 patients requiring Oxygen supplementation: A systematic review and meta-analysis

enthalten in: bioRxiv.org | 2021

von Elangovan, E. | Kumar, V. | Kathiravan, A. | +3

Tocilizumab in hospitalized patients with COVID-19: A meta analysis of randomized controlled trials

enthalten in: bioRxiv.org | 2021

von Selvaraj, V. | Khan, M. | Dapaah-Afriyie, K. | +4

Differential effect of corticosteroid treatment on Influenza, SARS, MERS, and SARS-CoV-2 patients: A meta-analysis and systematic review

enthalten in: bioRxiv.org | 2021

von Ali, S. | Uddin, S. | Dewan, M. | +8

Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy

enthalten in: bioRxiv.org | 2021

von Shabalin, I. | Czub, M. | Majorek, K. | +6

Corticosteroids and mortality in patients with severe Covid-19 who have autoantibodies

enthalten in: bioRxiv.org | 2021

von Cui, Z. | Roth, M. | Averbukh, Y. | +5

Early Short Course Corticosteroids in Hospitalized Patients with COVID-19

enthalten in: bioRxiv.org | 2021

von Fadel, R. | Morrison, A. | Vahia, A. | +7

Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection

enthalten in: bioRxiv.org | 2021

von Ferreira, A. | Oliveira-e-Silva, A. | Bettencourt, P.

Single-Arm, Open-Label Phase 2 Trial of Preemptive Methylprednisolone to Avert Progression to Respiratory Failure in High-Risk Patients with COVID-19

enthalten in: bioRxiv.org | 2021

von Cabanillas, F. | Morales, J. | G. Conde, J. | +6

A single-center retrospective cohort study of Covid-19 medications: Remdesivir, Favipiravir, Methylprednisolone, Dexamethasone, and Interferon β1a and their combinations

enthalten in: bioRxiv.org | 2021

von Fateh, S. | Fateh, S. | Salehi, E. | +4